These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24370386)

  • 1. Towards newborn screening for ornithine transcarbamylase deficiency: fast non-chromatographic orotic acid quantification from dried blood spots by tandem mass spectrometry.
    Janzen N; Terhardt M; Sander S; Demirkol M; Gökçay G; Peter M; Lücke T; Sander J; Das AM
    Clin Chim Acta; 2014 Mar; 430():28-32. PubMed ID: 24370386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots.
    Held PK; Haynes CA; De Jesús VR; Baker MW
    Clin Chim Acta; 2014 Sep; 436():149-54. PubMed ID: 24886687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.
    Auray-Blais C; Maranda B; Lavoie P
    Clin Chim Acta; 2014 Sep; 436():249-55. PubMed ID: 24909877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of orotic acid measurement in routine newborn screening for urea cycle disorders.
    Staretz-Chacham O; Daas S; Ulanovsky I; Blau A; Rostami N; Saraf-Levy T; Abu Salah N; Anikster Y; Banne E; Dar D; Dumin E; Fattal-Valevski A; Falik-Zaccai T; Hershkovitz E; Josefsberg S; Khammash H; Keidar R; Korman SH; Landau Y; Lerman-Sagie T; Mandel D; Mandel H; Marom R; Morag I; Nadir E; Yosha-Orpaz N; Pode-Shakked B; Pras E; Reznik-Wolf H; Saada A; Segel R; Shaag A; Shaul Lotan N; Spiegel R; Tal G; Vaisid T; Zeharia A; Almashanu S
    J Inherit Metab Dis; 2021 May; 44(3):606-617. PubMed ID: 33190319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference intervals for orotic acid in urine, plasma and dried blood spot using hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    D'Apolito O; Garofalo D; la Marca G; Dello Russo A; Corso G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():155-60. PubMed ID: 22019295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative method for acylcarnitines and amino acids using high resolution chromatography and tandem mass spectrometry in newborn screening dried blood spot analysis.
    Miller JH; Poston PA; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():142-9. PubMed ID: 22846691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of aromatic L-amino acid decarboxylase deficiency by measuring 3-O-methyldopa concentrations in dried blood spots.
    Chen PW; Lee NC; Chien YH; Wu JY; Wang PC; Hwu WL
    Clin Chim Acta; 2014 Apr; 431():19-22. PubMed ID: 24513538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis.
    Forni S; Fu X; Palmer SE; Sweetman L
    Mol Genet Metab; 2010 Sep; 101(1):25-32. PubMed ID: 20591710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening.
    Gucciardi A; Pirillo P; Di Gangi IM; Naturale M; Giordano G
    Anal Bioanal Chem; 2012 Aug; 404(3):741-51. PubMed ID: 22766757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of diagnostic biomarkers of alkaptonuria, ornithine carbamoyltransferase deficiency, and neuroblastoma disease by high-performance liquid chromatography/tandem mass spectrometry.
    Hsu WY; Chen CM; Tsai FJ; Lai CC
    Clin Chim Acta; 2013 May; 420():140-5. PubMed ID: 23085206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
    Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
    Golbahar J; Altayab DD; Carreon E
    J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency.
    Trinh MU; Blake J; Harrison JR; Gerace R; Ranieri E; Fletcher JM; Johnson DW
    Clin Chem; 2003 Apr; 49(4):681-4. PubMed ID: 12651832
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine.
    Metz TF; Mechtler TP; Merk M; Gottschalk A; Lukačin R; Herkner KR; Kasper DC
    Clin Chim Acta; 2012 Aug; 413(15-16):1259-64. PubMed ID: 22521492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UPLC-MS/MS analysis of C5-acylcarnitines in dried blood spots.
    Janzen N; Steuerwald U; Sander S; Terhardt M; Peter M; Sander J
    Clin Chim Acta; 2013 Jun; 421():41-5. PubMed ID: 23499962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
    Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
    Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.
    Engel K; Nuoffer JM; Mühlhausen C; Klaus V; Largiadèr CR; Tsiakas K; Santer R; Wermuth B; Häberle J
    Mol Genet Metab; 2008 Jul; 94(3):292-7. PubMed ID: 18440262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.